National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
MEDI-507

 A monoclonal antibody that is being studied in the treatment of certain lymphoproliferative disorders and psoriasis. Also called siplizumab.

Previous Definitions:mean survival time, measles virus, measurable disease, mechlorethamine, mechlorethamine hydrochloride
Next Definitions:MEDI-522, medial supraclavicular lymph node, median, median survival time, median umbilical ligament